Cargando…

Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer

OBJECTIVE: To investigate the survival outcomes in patients with bulky stage IIIC and IV ovarian cancer, treated by primary debulking surgery (PDS) and selective use of neoadjuvant chemotherapy (NAC) according to institutional criteria. METHODS: Medical records for advanced ovarian cancer patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Myong Cheol, Yoo, Heong Jong, Song, Yong Jung, Seo, Sang-Soo, Kang, Sokbom, Kim, Sun Ho, Yoo, Chong Woo, Park, Sang-Yoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447147/ https://www.ncbi.nlm.nih.gov/pubmed/28541636 http://dx.doi.org/10.3802/jgo.2017.28.e48

Ejemplares similares

Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study
por: Ren, Yulan, et al.
Publicado: (2015)

Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
por: Shin, Wonkyo, et al.
Publicado: (2020)

Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016)

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial
por: Lim, Myong Cheol, et al.
Publicado: (2022)

The survival effect of ovary preservation in early stage endometrial cancer: a single institution retrospective analysis
por: Shin, Wonkyo, et al.
Publicado: (2020)

Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea
por: Yoo, Heon Jong, et al.
Publicado: (2012)

The role of neoadjuvant chemotherapy in ovarian cancer patients with extensive tumor burden
por: Kang, Sokbom
Publicado: (2011)

Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012
por: Kim, Se Ik, et al.
Publicado: (2016)

Feasibility and Safety of Extensive Upper Abdominal Surgery in Elderly Patients with Advanced Epithelial Ovarian Cancer
por: Lim, Myong Cheol, et al.
Publicado: (2010)

Surgical outcomes of ureteral reconstruction during cytoreductive surgery for ovarian cancer: a retrospective cohort study
por: Kim, Ji Hyun, et al.
Publicado: (2022)

Cost-effectiveness of primary debulking surgery when compared to neoadjuvant chemotherapy in the management of stage IIIC and IV epithelial ovarian cancer
por: Forde, Gareth K, et al.
Publicado: (2016)

Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2016)

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
por: Škof, Erik, et al.
Publicado: (2016)

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy
por: Blankenstein, Stephanie A., et al.
Publicado: (2020)

Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
por: Choi, Chel Hun, et al.
Publicado: (2008)

Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons
por: Yoo, Heon Jong, et al.
Publicado: (2018)

Completeness of pedigree and family cancer history for ovarian cancer patients
por: Son, Yedong, et al.
Publicado: (2014)

How to manage synchronous endometrial and ovarian cancer patients?
por: Shin, Wonkyo, et al.
Publicado: (2021)

Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept
por: Jiang, Rong, et al.
Publicado: (2020)

Improved Postoperative Pain Control for Cytoreductive Surgery in Women With Ovarian Cancer Using Patient-Controlled Epidural Analgesia
por: Oh, Tak Kyu, et al.
Publicado: (2016)

Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study
por: Duan, Hui, et al.
Publicado: (2023)

Tozzi classification of diaphragmatic surgery in patients with stage IIIC–IV ovarian cancer based on surgical findings and complexity
por: Tozzi, Roberto, et al.
Publicado: (2019)

Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer
por: Aigner, Karl R., et al.
Publicado: (2021)

Health Behaviors and Associated Sociodemographic Factors in Cervical Cancer Survivors Compared with Matched Non-Cancer Controls
por: Park, Boyoung, et al.
Publicado: (2016)

Clinical Characteristics and Changes of Clinical Features in Patients with Asthma-COPD Overlap in Korea according to Different Diagnostic Criteria
por: Lim, Jeong Uk, et al.
Publicado: (2020)

Treatment for Locally Resectable Stage IIIC1 Cervical Cancer: A Retrospective, Single-Institution Study
por: Kashima, Yoko, et al.
Publicado: (2023)

Lower extremity edema in patients with early ovarian cancer
por: Lim, Myong Cheol, et al.
Publicado: (2014)

The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing
por: Shin, Wonkyo, et al.
Publicado: (2021)

Addendum: Shin, W.; et al. The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing. Int. J. Environ. Res. Public Health 2021, 18, 2312
por: Shin, Wonkyo, et al.
Publicado: (2021)

Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer
por: Rutten, Marianne J., et al.
Publicado: (2015)

Feasibility of laparoscopic diaphragmatic peritonectomy during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer
por: Tozzi, Roberto, et al.
Publicado: (2020)

OrienX010, an oncolytic virus, in patients with unresectable stage IIIC–IV melanoma: a phase Ib study
por: Cui, ChuanLiang, et al.
Publicado: (2022)

521. Investigating the Gram-Positive Selective Spectrum of Ibezapolstat, a First-in-Class DNA Polymerase IIIC (Pol IIIC) Inhibitor
por: Jahangir Alam, M, et al.
Publicado: (2022)

Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression
por: Jethwa, Krishan R., et al.
Publicado: (2016)

Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer
por: Son, Joo-Hyuk, et al.
Publicado: (2022)

Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer
por: Li, Jing, et al.
Publicado: (2016)

Neoadjuvant chemoradiotherapy for locally advanced gastric cancer with bulky lymph node metastasis: Five case reports
por: Nomura, Eiji, et al.
Publicado: (2020)

A multi-institutional analysis of sequential versus ‘sandwich’ adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma
por: Onal, Cem, et al.
Publicado: (2018)

Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review
por: Beal, Eliza W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r4jk3um8qfg69dcup18dc77psi